FDA.reportPublic FDA data

rotigotine 0.0417 MG/HR 24 HR Transdermal Patch

RxCUI
1251912
RxNorm name
rotigotine 0.0417 MG/HR 24 HR Transdermal Patch
Display name
rotigotine 0.0417 MG/HR 24 HR Transdermal Patch
Full name
rotigotine 0.0417 MG/HR 24 HR Transdermal Patch
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
939e28c5-f3a9-42c0-9a2d-8d471d82a6e0rotigotine 1 MG/Day 24HR Transdermal System [PSN] · 24 HR rotigotine 0.0417 MG/HR Transdermal System [SCD] · rotigotine 0.0417 MG/HR 24 HR Transdermal Patch [SY] · rotigotine 1 MG/Day 24 HR Transdermal Patch [SY] · rotigotine 1 MG/Day 24HR Transdermal System [SY]520These highlights do not include all the information needed to use NEUPRO safely and effectively. See full prescribing information for NEUPRO. NEUPRO (rotigotine transdermal system) Initial U.S. Approval: 200720250624